Andblogmoney

 In a strategic policy shift, the Indian government is preparing to roll out a customised incentive scheme for the domestic toy industry, moving away from the Production Linked Incentive (PLI) model that had long been anticipated for the sector. According to a senior official, the proposed scheme is expected to mirror the structure of the recently introduced Electronics Component Manufacturing Scheme (ECMS), which offers differentiated incentives based on turnover, capital expenditure (capex), or a combination of both. "We are bringing in a sector-specific scheme for toys. It won't be under the PLI framework, but the objective is similar to what the government achieved with smartphones. The concerned ministry is finalising the details," the official said on May 19. The PLI scheme, launched to boost manufacturing across multiple sectors, offers financial rewards tied to measurable outcomes like increased production and sales. While successful in areas such as smartphone ...

  Traveling is exciting, but flight prices can quickly turn your trip into a costly affair. Thankfully,   Product-Bank   is here to help you find the cheapest flights with minimal effort. Whether you're booking domestic or international flights, using Product-Bank’s advanced features will maximize your chances of scoring budget-friendly tickets. One of the most effective ways to find cheap flights is by searching across multiple airlines simultaneously. Product-Bank’s search engine aggregates flights from a wide range of airlines and online travel agencies, so you don’t have to visit several websites. This comprehensive approach saves you time and ensures you see the best prices available. Product-Bank also suggests booking flights during “shoulder seasons,” the periods just before or after peak travel times. During these times, airlines often reduce prices to fill seats, offering travelers cheaper options. Product-Bank’s calendar view helps you identify these dates, mak...

 Former President Donald Trump has revived his pledge to lower prescription drug prices if re-elected. However, systemic barriers—including entrenched pharmaceutical lobbying, complex regulatory pathways, and economic reliance on pharma innovation—make substantial reform challenging. Even previously proposed measures faced legal pushback and political gridlock. While populist rhetoric on drug pricing appeals to voters, actual structural reform is likely to be slow and contentious. If you can provide the article text, I can rewrite the entire piece for you.